Global Memantine Hydrochloride Extended-Release Capsule Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Memantine Hydrochloride Extended-Release Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Memantine Hydrochloride Extended-Release Capsule.
The Memantine Hydrochloride Extended-Release Capsule market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Memantine Hydrochloride Extended-Release Capsule market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Memantine Hydrochloride Extended-Release Capsule companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Extended-Release Capsule companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Memantine Hydrochloride Extended-Release Capsule market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Memantine Hydrochloride Extended-Release Capsule market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Memantine Hydrochloride Extended-Release Capsule companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Lundbeck
- Allergan
- Novartis AG
- Lupin Ltd
- Huahai Pharmaceutical
- Daiichi Sankyo Company Limited
- Rottendorf Pharma GmbH
- Polygen Pharms
- Macleods Pharms Ltd
- Amneal Pharms
- Apeloa Pharmaceutical
- HUMANWELL GROUP
- Eisai Co
- Ono Pharmaceutical Co Ltd
- Slate Run
- 7mg
- 14mg
- 21mg
- 28mg
- Others
- Home
- Hospital
- Clinic
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Memantine Hydrochloride Extended-Release Capsule companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 7mg
1.2.3 14mg
1.2.4 21mg
1.2.5 28mg
1.2.6 Others
1.3 Market by Application
1.3.1 Global Memantine Hydrochloride Extended-Release Capsule Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Perspective (2018-2029)
2.2 Memantine Hydrochloride Extended-Release Capsule Growth Trends by Region
2.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Region (2018-2023)
2.2.3 Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2024-2029)
2.3 Memantine Hydrochloride Extended-Release Capsule Market Dynamics
2.3.1 Memantine Hydrochloride Extended-Release Capsule Industry Trends
2.3.2 Memantine Hydrochloride Extended-Release Capsule Market Drivers
2.3.3 Memantine Hydrochloride Extended-Release Capsule Market Challenges
2.3.4 Memantine Hydrochloride Extended-Release Capsule Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue
3.1.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue (2018-2023)
3.1.2 Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Players (2018-2023)
3.2 Global Memantine Hydrochloride Extended-Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Memantine Hydrochloride Extended-Release Capsule Revenue
3.4 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio
3.4.1 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Memantine Hydrochloride Extended-Release Capsule Revenue in 2022
3.5 Memantine Hydrochloride Extended-Release Capsule Key Players Head office and Area Served
3.6 Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
3.7 Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE BREAKDOWN DATA BY TYPE
4.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Type (2018-2023)
4.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2024-2029)
5 MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE BREAKDOWN DATA BY APPLICATION
5.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Application (2018-2023)
5.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
6.2 North America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
6.4 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
7.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
7.4 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
8.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023)
8.4 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
9.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
9.4 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
10.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
10.4 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Lundbeck
11.1.1 Lundbeck Company Detail
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck Memantine Hydrochloride Extended-Release Capsule Introduction
11.1.4 Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.1.5 Lundbeck Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Memantine Hydrochloride Extended-Release Capsule Introduction
11.2.4 Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Memantine Hydrochloride Extended-Release Capsule Introduction
11.3.4 Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Lupin Ltd
11.4.1 Lupin Ltd Company Detail
11.4.2 Lupin Ltd Business Overview
11.4.3 Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.4.4 Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.4.5 Lupin Ltd Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Detail
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.5.4 Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Company Detail
11.6.2 Daiichi Sankyo Company Limited Business Overview
11.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Introduction
11.6.4 Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.6.5 Daiichi Sankyo Company Limited Recent Development
11.7 Rottendorf Pharma GmbH
11.7.1 Rottendorf Pharma GmbH Company Detail
11.7.2 Rottendorf Pharma GmbH Business Overview
11.7.3 Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Introduction
11.7.4 Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.7.5 Rottendorf Pharma GmbH Recent Development
11.8 Polygen Pharms
11.8.1 Polygen Pharms Company Detail
11.8.2 Polygen Pharms Business Overview
11.8.3 Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.8.4 Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.8.5 Polygen Pharms Recent Development
11.9 Macleods Pharms Ltd
11.9.1 Macleods Pharms Ltd Company Detail
11.9.2 Macleods Pharms Ltd Business Overview
11.9.3 Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.9.4 Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.9.5 Macleods Pharms Ltd Recent Development
11.10 Amneal Pharms
11.10.1 Amneal Pharms Company Detail
11.10.2 Amneal Pharms Business Overview
11.10.3 Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.10.4 Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.10.5 Amneal Pharms Recent Development
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Detail
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.11.5 Apeloa Pharmaceutical Recent Development
11.12 HUMANWELL GROUP
11.12.1 HUMANWELL GROUP Company Detail
11.12.2 HUMANWELL GROUP Business Overview
11.12.3 HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Introduction
11.12.4 HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.12.5 HUMANWELL GROUP Recent Development
11.13 Eisai Co
11.13.1 Eisai Co Company Detail
11.13.2 Eisai Co Business Overview
11.13.3 Eisai Co Memantine Hydrochloride Extended-Release Capsule Introduction
11.13.4 Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.13.5 Eisai Co Recent Development
11.14 Ono Pharmaceutical Co Ltd
11.14.1 Ono Pharmaceutical Co Ltd Company Detail
11.14.2 Ono Pharmaceutical Co Ltd Business Overview
11.14.3 Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.14.4 Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.14.5 Ono Pharmaceutical Co Ltd Recent Development
11.15 Slate Run
11.15.1 Slate Run Company Detail
11.15.2 Slate Run Business Overview
11.15.3 Slate Run Memantine Hydrochloride Extended-Release Capsule Introduction
11.15.4 Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.15.5 Slate Run Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 7mg
1.2.3 14mg
1.2.4 21mg
1.2.5 28mg
1.2.6 Others
1.3 Market by Application
1.3.1 Global Memantine Hydrochloride Extended-Release Capsule Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Perspective (2018-2029)
2.2 Memantine Hydrochloride Extended-Release Capsule Growth Trends by Region
2.2.1 Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Region (2018-2023)
2.2.3 Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2024-2029)
2.3 Memantine Hydrochloride Extended-Release Capsule Market Dynamics
2.3.1 Memantine Hydrochloride Extended-Release Capsule Industry Trends
2.3.2 Memantine Hydrochloride Extended-Release Capsule Market Drivers
2.3.3 Memantine Hydrochloride Extended-Release Capsule Market Challenges
2.3.4 Memantine Hydrochloride Extended-Release Capsule Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue
3.1.1 Global Top Memantine Hydrochloride Extended-Release Capsule Players by Revenue (2018-2023)
3.1.2 Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Players (2018-2023)
3.2 Global Memantine Hydrochloride Extended-Release Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Memantine Hydrochloride Extended-Release Capsule Revenue
3.4 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio
3.4.1 Global Memantine Hydrochloride Extended-Release Capsule Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Memantine Hydrochloride Extended-Release Capsule Revenue in 2022
3.5 Memantine Hydrochloride Extended-Release Capsule Key Players Head office and Area Served
3.6 Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
3.7 Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE BREAKDOWN DATA BY TYPE
4.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Type (2018-2023)
4.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2024-2029)
5 MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE BREAKDOWN DATA BY APPLICATION
5.1 Global Memantine Hydrochloride Extended-Release Capsule Historic Market Size by Application (2018-2023)
5.2 Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
6.2 North America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
6.4 North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
7.2 Europe Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
7.4 Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
8.2 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023)
8.4 Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
9.2 Latin America Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
9.4 Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size (2018-2029)
10.2 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023)
10.4 Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Lundbeck
11.1.1 Lundbeck Company Detail
11.1.2 Lundbeck Business Overview
11.1.3 Lundbeck Memantine Hydrochloride Extended-Release Capsule Introduction
11.1.4 Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.1.5 Lundbeck Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Memantine Hydrochloride Extended-Release Capsule Introduction
11.2.4 Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Memantine Hydrochloride Extended-Release Capsule Introduction
11.3.4 Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Lupin Ltd
11.4.1 Lupin Ltd Company Detail
11.4.2 Lupin Ltd Business Overview
11.4.3 Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.4.4 Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.4.5 Lupin Ltd Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Detail
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.5.4 Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Company Detail
11.6.2 Daiichi Sankyo Company Limited Business Overview
11.6.3 Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Introduction
11.6.4 Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.6.5 Daiichi Sankyo Company Limited Recent Development
11.7 Rottendorf Pharma GmbH
11.7.1 Rottendorf Pharma GmbH Company Detail
11.7.2 Rottendorf Pharma GmbH Business Overview
11.7.3 Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Introduction
11.7.4 Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.7.5 Rottendorf Pharma GmbH Recent Development
11.8 Polygen Pharms
11.8.1 Polygen Pharms Company Detail
11.8.2 Polygen Pharms Business Overview
11.8.3 Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.8.4 Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.8.5 Polygen Pharms Recent Development
11.9 Macleods Pharms Ltd
11.9.1 Macleods Pharms Ltd Company Detail
11.9.2 Macleods Pharms Ltd Business Overview
11.9.3 Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.9.4 Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.9.5 Macleods Pharms Ltd Recent Development
11.10 Amneal Pharms
11.10.1 Amneal Pharms Company Detail
11.10.2 Amneal Pharms Business Overview
11.10.3 Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Introduction
11.10.4 Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.10.5 Amneal Pharms Recent Development
11.11 Apeloa Pharmaceutical
11.11.1 Apeloa Pharmaceutical Company Detail
11.11.2 Apeloa Pharmaceutical Business Overview
11.11.3 Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Introduction
11.11.4 Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.11.5 Apeloa Pharmaceutical Recent Development
11.12 HUMANWELL GROUP
11.12.1 HUMANWELL GROUP Company Detail
11.12.2 HUMANWELL GROUP Business Overview
11.12.3 HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Introduction
11.12.4 HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.12.5 HUMANWELL GROUP Recent Development
11.13 Eisai Co
11.13.1 Eisai Co Company Detail
11.13.2 Eisai Co Business Overview
11.13.3 Eisai Co Memantine Hydrochloride Extended-Release Capsule Introduction
11.13.4 Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.13.5 Eisai Co Recent Development
11.14 Ono Pharmaceutical Co Ltd
11.14.1 Ono Pharmaceutical Co Ltd Company Detail
11.14.2 Ono Pharmaceutical Co Ltd Business Overview
11.14.3 Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Introduction
11.14.4 Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.14.5 Ono Pharmaceutical Co Ltd Recent Development
11.15 Slate Run
11.15.1 Slate Run Company Detail
11.15.2 Slate Run Business Overview
11.15.3 Slate Run Memantine Hydrochloride Extended-Release Capsule Introduction
11.15.4 Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
11.15.5 Slate Run Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 7mg
Table 3. Key Players of 14mg
Table 4. Key Players of 21mg
Table 5. Key Players of 28mg
Table 6. Key Players of Others
Table 7. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2018-2023)
Table 11. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2024-2029)
Table 13. Memantine Hydrochloride Extended-Release Capsule Market Trends
Table 14. Memantine Hydrochloride Extended-Release Capsule Market Drivers
Table 15. Memantine Hydrochloride Extended-Release Capsule Market Challenges
Table 16. Memantine Hydrochloride Extended-Release Capsule Market Restraints
Table 17. Global Memantine Hydrochloride Extended-Release Capsule Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players (2018-2023)
Table 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2022)
Table 20. Ranking of Global Top Memantine Hydrochloride Extended-Release Capsule Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
Table 24. Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2018-2023)
Table 28. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2024-2029)
Table 30. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2018-2023)
Table 32. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2024-2029)
Table 34. North America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 49. Lundbeck Company Detail
Table 50. Lundbeck Business Overview
Table 51. Lundbeck Memantine Hydrochloride Extended-Release Capsule Product
Table 52. Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 53. Lundbeck Recent Development
Table 54. Allergan Company Detail
Table 55. Allergan Business Overview
Table 56. Allergan Memantine Hydrochloride Extended-Release Capsule Product
Table 57. Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Novartis AG Company Detail
Table 60. Novartis AG Business Overview
Table 61. Novartis AG Memantine Hydrochloride Extended-Release Capsule Product
Table 62. Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 63. Novartis AG Recent Development
Table 64. Lupin Ltd Company Detail
Table 65. Lupin Ltd Business Overview
Table 66. Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 67. Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 68. Lupin Ltd Recent Development
Table 69. Huahai Pharmaceutical Company Detail
Table 70. Huahai Pharmaceutical Business Overview
Table 71. Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 72. Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 73. Huahai Pharmaceutical Recent Development
Table 74. Daiichi Sankyo Company Limited Company Detail
Table 75. Daiichi Sankyo Company Limited Business Overview
Table 76. Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Product
Table 77. Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 78. Daiichi Sankyo Company Limited Recent Development
Table 79. Rottendorf Pharma GmbH Company Detail
Table 80. Rottendorf Pharma GmbH Business Overview
Table 81. Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Product
Table 82. Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 83. Rottendorf Pharma GmbH Recent Development
Table 84. Polygen Pharms Company Detail
Table 85. Polygen Pharms Business Overview
Table 86. Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 87. Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 88. Polygen Pharms Recent Development
Table 89. Macleods Pharms Ltd Company Detail
Table 90. Macleods Pharms Ltd Business Overview
Table 91. Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 92. Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 93. Macleods Pharms Ltd Recent Development
Table 94. Amneal Pharms Company Detail
Table 95. Amneal Pharms Business Overview
Table 96. Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 97. Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 98. Amneal Pharms Recent Development
Table 99. Apeloa Pharmaceutical Company Detail
Table 100. Apeloa Pharmaceutical Business Overview
Table 101. Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 102. Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 103. Apeloa Pharmaceutical Recent Development
Table 104. HUMANWELL GROUP Company Detail
Table 105. HUMANWELL GROUP Business Overview
Table 106. HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Product
Table 107. HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 108. HUMANWELL GROUP Recent Development
Table 109. Eisai Co Company Detail
Table 110. Eisai Co Business Overview
Table 111. Eisai Co Memantine Hydrochloride Extended-Release Capsule Product
Table 112. Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 113. Eisai Co Recent Development
Table 114. Ono Pharmaceutical Co Ltd Company Detail
Table 115. Ono Pharmaceutical Co Ltd Business Overview
Table 116. Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 117. Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 118. Ono Pharmaceutical Co Ltd Recent Development
Table 119. Slate Run Company Detail
Table 120. Slate Run Business Overview
Table 121. Slate Run Memantine Hydrochloride Extended-Release Capsule Product
Table 122. Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 123. Slate Run Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 7mg
Table 3. Key Players of 14mg
Table 4. Key Players of 21mg
Table 5. Key Players of 28mg
Table 6. Key Players of Others
Table 7. Global Memantine Hydrochloride Extended-Release Capsule Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2018-2023)
Table 11. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2024-2029)
Table 13. Memantine Hydrochloride Extended-Release Capsule Market Trends
Table 14. Memantine Hydrochloride Extended-Release Capsule Market Drivers
Table 15. Memantine Hydrochloride Extended-Release Capsule Market Challenges
Table 16. Memantine Hydrochloride Extended-Release Capsule Market Restraints
Table 17. Global Memantine Hydrochloride Extended-Release Capsule Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players (2018-2023)
Table 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2022)
Table 20. Ranking of Global Top Memantine Hydrochloride Extended-Release Capsule Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Memantine Hydrochloride Extended-Release Capsule Product Solution and Service
Table 24. Date of Enter into Memantine Hydrochloride Extended-Release Capsule Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2018-2023)
Table 28. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Type (2024-2029)
Table 30. Global Memantine Hydrochloride Extended-Release Capsule Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2018-2023)
Table 32. Global Memantine Hydrochloride Extended-Release Capsule Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Memantine Hydrochloride Extended-Release Capsule Revenue Market Share by Application (2024-2029)
Table 34. North America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size by Country (2024-2029) & (US$ Million)
Table 49. Lundbeck Company Detail
Table 50. Lundbeck Business Overview
Table 51. Lundbeck Memantine Hydrochloride Extended-Release Capsule Product
Table 52. Lundbeck Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 53. Lundbeck Recent Development
Table 54. Allergan Company Detail
Table 55. Allergan Business Overview
Table 56. Allergan Memantine Hydrochloride Extended-Release Capsule Product
Table 57. Allergan Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Novartis AG Company Detail
Table 60. Novartis AG Business Overview
Table 61. Novartis AG Memantine Hydrochloride Extended-Release Capsule Product
Table 62. Novartis AG Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 63. Novartis AG Recent Development
Table 64. Lupin Ltd Company Detail
Table 65. Lupin Ltd Business Overview
Table 66. Lupin Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 67. Lupin Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 68. Lupin Ltd Recent Development
Table 69. Huahai Pharmaceutical Company Detail
Table 70. Huahai Pharmaceutical Business Overview
Table 71. Huahai Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 72. Huahai Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 73. Huahai Pharmaceutical Recent Development
Table 74. Daiichi Sankyo Company Limited Company Detail
Table 75. Daiichi Sankyo Company Limited Business Overview
Table 76. Daiichi Sankyo Company Limited Memantine Hydrochloride Extended-Release Capsule Product
Table 77. Daiichi Sankyo Company Limited Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 78. Daiichi Sankyo Company Limited Recent Development
Table 79. Rottendorf Pharma GmbH Company Detail
Table 80. Rottendorf Pharma GmbH Business Overview
Table 81. Rottendorf Pharma GmbH Memantine Hydrochloride Extended-Release Capsule Product
Table 82. Rottendorf Pharma GmbH Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 83. Rottendorf Pharma GmbH Recent Development
Table 84. Polygen Pharms Company Detail
Table 85. Polygen Pharms Business Overview
Table 86. Polygen Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 87. Polygen Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 88. Polygen Pharms Recent Development
Table 89. Macleods Pharms Ltd Company Detail
Table 90. Macleods Pharms Ltd Business Overview
Table 91. Macleods Pharms Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 92. Macleods Pharms Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 93. Macleods Pharms Ltd Recent Development
Table 94. Amneal Pharms Company Detail
Table 95. Amneal Pharms Business Overview
Table 96. Amneal Pharms Memantine Hydrochloride Extended-Release Capsule Product
Table 97. Amneal Pharms Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 98. Amneal Pharms Recent Development
Table 99. Apeloa Pharmaceutical Company Detail
Table 100. Apeloa Pharmaceutical Business Overview
Table 101. Apeloa Pharmaceutical Memantine Hydrochloride Extended-Release Capsule Product
Table 102. Apeloa Pharmaceutical Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 103. Apeloa Pharmaceutical Recent Development
Table 104. HUMANWELL GROUP Company Detail
Table 105. HUMANWELL GROUP Business Overview
Table 106. HUMANWELL GROUP Memantine Hydrochloride Extended-Release Capsule Product
Table 107. HUMANWELL GROUP Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 108. HUMANWELL GROUP Recent Development
Table 109. Eisai Co Company Detail
Table 110. Eisai Co Business Overview
Table 111. Eisai Co Memantine Hydrochloride Extended-Release Capsule Product
Table 112. Eisai Co Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 113. Eisai Co Recent Development
Table 114. Ono Pharmaceutical Co Ltd Company Detail
Table 115. Ono Pharmaceutical Co Ltd Business Overview
Table 116. Ono Pharmaceutical Co Ltd Memantine Hydrochloride Extended-Release Capsule Product
Table 117. Ono Pharmaceutical Co Ltd Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 118. Ono Pharmaceutical Co Ltd Recent Development
Table 119. Slate Run Company Detail
Table 120. Slate Run Business Overview
Table 121. Slate Run Memantine Hydrochloride Extended-Release Capsule Product
Table 122. Slate Run Revenue in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023) & (US$ Million)
Table 123. Slate Run Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Type: 2022 VS 2029
Figure 3. 7mg Features
Figure 4. 14mg Features
Figure 5. 21mg Features
Figure 6. 28mg Features
Figure 7. Others Features
Figure 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Application: 2022 VS 2029
Figure 10. Home Case Studies
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Memantine Hydrochloride Extended-Release Capsule Report Years Considered
Figure 15. Global Memantine Hydrochloride Extended-Release Capsule Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Memantine Hydrochloride Extended-Release Capsule Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region: 2022 VS 2029
Figure 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players in 2022
Figure 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue in 2022
Figure 21. North America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 23. United States Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 27. Germany Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2018-2029)
Figure 35. China Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 43. Mexico Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 47. Turkey Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Lundbeck Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 50. Allergan Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 51. Novartis AG Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 52. Lupin Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 53. Huahai Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 54. Daiichi Sankyo Company Limited Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 55. Rottendorf Pharma GmbH Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 56. Polygen Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 57. Macleods Pharms Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 58. Amneal Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 59. Apeloa Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 60. HUMANWELL GROUP Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 61. Eisai Co Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 62. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 63. Slate Run Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Type: 2022 VS 2029
Figure 3. 7mg Features
Figure 4. 14mg Features
Figure 5. 21mg Features
Figure 6. 28mg Features
Figure 7. Others Features
Figure 8. Global Memantine Hydrochloride Extended-Release Capsule Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Application: 2022 VS 2029
Figure 10. Home Case Studies
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Memantine Hydrochloride Extended-Release Capsule Report Years Considered
Figure 15. Global Memantine Hydrochloride Extended-Release Capsule Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Memantine Hydrochloride Extended-Release Capsule Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Region: 2022 VS 2029
Figure 18. Global Memantine Hydrochloride Extended-Release Capsule Market Share by Players in 2022
Figure 19. Global Top Memantine Hydrochloride Extended-Release Capsule Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Memantine Hydrochloride Extended-Release Capsule as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Memantine Hydrochloride Extended-Release Capsule Revenue in 2022
Figure 21. North America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 23. United States Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 27. Germany Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Memantine Hydrochloride Extended-Release Capsule Market Share by Region (2018-2029)
Figure 35. China Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 43. Mexico Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Memantine Hydrochloride Extended-Release Capsule Market Share by Country (2018-2029)
Figure 47. Turkey Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Memantine Hydrochloride Extended-Release Capsule Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Lundbeck Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 50. Allergan Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 51. Novartis AG Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 52. Lupin Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 53. Huahai Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 54. Daiichi Sankyo Company Limited Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 55. Rottendorf Pharma GmbH Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 56. Polygen Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 57. Macleods Pharms Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 58. Amneal Pharms Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 59. Apeloa Pharmaceutical Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 60. HUMANWELL GROUP Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 61. Eisai Co Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 62. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 63. Slate Run Revenue Growth Rate in Memantine Hydrochloride Extended-Release Capsule Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
